Doxycycline and Chalazion - a phase IV clinical study of FDA data
Chalazion is reported only by a few people who take Doxycycline.
The phase IV clinical study analyzes which people take Doxycycline and have Chalazion. It is created by eHealthMe based on reports of 53,763 people who have side effects while taking Doxycycline from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
53,763 people reported to have side effects when taking Doxycycline.
Among them, 3 people (0.01%) have Chalazion.
What is Doxycycline?
Doxycycline has active ingredients of doxycycline hyclate. It is often used in acne. eHealthMe is studying from 53,921 Doxycycline users for its effectiveness, alternative drugs and more.
What is Chalazion?
Chalazion (cyst in the eyelid) is found to be associated with 381 drugs and 188 conditions by eHealthMe.
Number of Doxycycline and Chalazion reports submitted per year:
Gender of people who have Chalazion when taking Doxycycline *:
- female: 100 %
- male: 0.0 %
Age of people who have Chalazion when taking Doxycycline *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 50 %
- 50-59: 50 %
- 60+: 0.0 %
Common drugs people take besides Doxycycline *:
- Zometa: 1 person, 33.33%
- Lidocaine: 1 person, 33.33%
- Avonex: 1 person, 33.33%
- Clonazepam: 1 person, 33.33%
- Cymbalta: 1 person, 33.33%
- Decadron: 1 person, 33.33%
- Depo-Medrol: 1 person, 33.33%
- Elidel: 1 person, 33.33%
- Glipizide: 1 person, 33.33%
- Hydrochlorothiazide: 1 person, 33.33%
Common side effects people have besides Chalazion *:
- Vision Blurred: 2 people, 66.67%
- Weight Loss: 1 person, 33.33%
- Fatigue (feeling of tiredness): 1 person, 33.33%
- Decreased Interest: 1 person, 33.33%
- Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 33.33%
- Diarrhea: 1 person, 33.33%
- Diverticulum Intestinal (a pouch that is attached to the first part of the small intestine): 1 person, 33.33%
- Dry Eyes (lack of adequate tears): 1 person, 33.33%
- Dry Mouth: 1 person, 33.33%
- Embolism Venous (embolus may pass into the arterial system): 1 person, 33.33%
Common conditions people have *:
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 33.33%
- Multiple Myeloma (cancer of the plasma cells): 1 person, 33.33%
- Dermatitis Contact (skin reaction (dermatitis) resulting from exposure to allergens): 1 person, 33.33%
* Approximation only. Some reports may have incomplete information.
Do you take Doxycycline and have Chalazion?Check whether Chalazion is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Chalazion and when was it recovered:
Expand to all the drugs that have ingredients of doxycycline hyclate:
Alternative drugs to, pros and cons of Doxycycline:
- Doxycycline (53,921 reports)
Common Doxycycline side effects:
Browse all side effects of Doxycycline:a b c d e f g h i j k l m n o p q r s t u v w x y z
Chalazion treatments and more:
- Chalazion (623 reports)
COVID vaccines that are related to Chalazion:
- Chalazion in Moderna COVID Vaccine
- Chalazion in Pfizer BioNTech Covid Vaccine
- Chalazion in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Chalazion:
- Chalazion (381 drugs)
All the conditions that are associated with Chalazion:
- Chalazion (188 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on doxycycline hyclate (the active ingredients of Doxycycline) and Doxycycline (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lortab vs. Ativan - now
- Nerve Injury and Fatigue - a second ago
- Hydroxychloroquine Sulfate and Dupuytren'S Contracture - a second ago
- Neuralgia and Irritability - 3 seconds ago
- Atropine and Ischaemic Neuropathy - 3 seconds ago
- Lasix and Obstructive Airways Disorder - 15 seconds ago
- Soriatane and Senna drug interaction - 19 seconds ago
- Mepron and Abdominal Pain - 20 seconds ago
- Enjuvia and Savella drug interaction - 22 seconds ago
- Cytomel and Spinal Column Stenosis - 27 seconds ago